Home › Polycythemia Vera › Virginia
Polycythemia Vera clinical trials in Virginia
4 studies for Polycythemia Vera are looking for participants at sites in Virginia.
A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).
- University of Virginia ( Site 5031), Charlottesville
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07722611INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- Hematology Oncology Associates of Fredericksburg, Fredericksburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07429266A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06661915Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- The James Cancer Hospital and Solove Research Institute, Roanoke
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT06093672From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.